McKenna's Pharmacology for Nursing, 2e

975

Index

therapeutic actions and indications, 151, 153 Azoles, definition, 150 Aztreonam, 91, 104–105, 122, 123 B B cells, 228, 233–234 suppressors, 263, 266 Bacille Calmette-Guerin (BCG) vaccine, 274, 279 Baclofen, 385, 386, 388–389, 390 Bacterial vaccines, 273, 279 Bactericidal drugs, 81, 83 Bacteriostatic drugs, 81, 83 Balsalazide, 242, 923 Barberry, 963 Barbiturates and barbiturate-like drugs, 67, 303, 357, 358–359 adverse effects, 359 anaesthetics, 416, 419–420 contraindications and cautions, 359 drug–drug interactions, 359 pharmacokinetics, 359 therapeutic actions and indications, 358 used as anxiolytic/hypnotics, 310–312 adverse effects, 311 care considerations, 312 contraindications and cautions, 311 drug–drug interactions, 311–312 pharmacokinetics, 310 therapeutic actions and indications, 310 Baroreceptors, 657–659 Barrier defences, 229–230 gastric acid, 229 major histocompatibility complex, 228, 229–230 mucous membranes, 229 skin, 229 Basal ganglia, 385, 386 Basil, 963 Basiliximab, 258, 264, 266, 267 Basophils, 230 Bayberry, 963 Beclomethasone, 539–541, 847, 851, 875, 877 Bee pollen, 632, 963 Belladonna, 501, 502 Bendroflumethiazide, 805 Benign prostatic hyperplasia (BPH) contraindications and cautions, 829 drug–drug interactions, 829–830 pharmacokinetics, 829 therapeutic actions and indications, 829 Benzalkonium chloride, 950 Benzathine penicillin, 109 Benzhexol, 379 Benzocaine, 417, 425, 426 Benzodiazepines, 67, 200, 303, 305, 357, 359–360 adverse effects, 360 antidote, 308 drugs for, 828–830 adverse effects, 829 care considerations, 830

contraindications and cautions, 360 critical thinking scenario, 309–310 drug–drug interactions, 360 pharmacokinetics, 360 sites of action, 306 therapeutic actions and indications, 359 used as anxiolytics, 305–310 adverse effects, 307 care considerations, 307–308 contraindications and cautions, 306–307 drug–drug interactions, 307 pharmacokinetics, 306 therapeutic actions and indications, 306 Benztropine, 379 Benzylpenicillin, 108, 109 Beractant, 865, 881–882 Beta-adrenergic agonists. See Adrenergic agonists Beta-blocking agents. See Adrenergic blocking agents Beta-receptors, 444, 448 subdivision, 456–457 Beta-specific adrenergic agonists, 465–467 adverse effects, 466 care considerations, 466–467 contraindications and cautions, 466 drug–drug interactions, 466 pharmacokinetics, 465 therapeutic actions and indications, 465 Beta 1 -selective adrenergic blocking agents, 469, 482–484 adverse effects, 483 care considerations, 484 contraindications and cautions, 483 drug–drug interactions, 483 pharmacokinetics, 483 therapeutic actions and indications, 482–483 Betamethasone, 539–541, 953 Betaxolol, 482, 675, 956 Betel palm, 963 Bethanechol, 487, 488–490 Bevacizumab, 266 Bilberry, 963 Bile, 888, 891 Bile acid, 729, 731 Bile acid sequestrants, 729, 735, 737, 739–740 adverse effects, 737 care considerations, 739–740 contraindications and cautions, 737 drug–drug interactions, 737 pharmacokinetics, 737 therapeutic actions and indications, 735–737 Bicalutamide, 212, 213 Biguanide, 573, 586, 588

Biotransformation (metabolism), 15, 23 drug–drug or drug–alternative therapy interactions, 28 Biperiden, 372, 379–380 Bipolar disorder, 334, 335 Birch bark, 963 Birth control, 611–612, 616–617 Bisacodyl, 918, 920 Bisoprolol, 471, 482 Bisphosphonates, 551, 552, 554, 567–569 adverse effects, 568 contraindications and cautions, 568 drug–drug interactions, 568 pharmacokinetics, 567–568 therapeutic actions and indications, 567 Bivalirudin, 756, 759–760 Black cohosh, 613, 963 Blackberry, 963 Bladder. See Urinary tract and bladder, drugs affecting Bleomycin, 205 Blood–brain barrier, 22 Blood coagulation. See Coagulation, drugs affecting Blood dyscrasia, 31, 35 Blood glucose levels, agents to control. See Glucose levels, agents to control Blood pressure, control, 657–662, 799 baroreceptors, 657–659 hypertension, 660–661 hypotension, 657, 661–662 renin–angiotensin–aldosterone system, 657, 659–660 Blood pressure, drugs affecting, 657–678 adults, 666–667 antihypertensive agents. See Antihypertensive agents antihypotensive agents, 676–678 alpha-specific adrenergic agents, 677–678 sympathetic adrenergic agonists or vasopressors, 676–677 children, 666 older adults, 667 Boceprevir, 144, 145 Body fluids, maintenance of, 797–799 Bone marrow disorders, 767 Bone marrow suppression, 190, 195 Borage, 613 Boric acid ointment, 950 Bortezomib, 220, 221 Botulinum toxin, 386, 390–392 Botulism, 282 Bovine colostrum, 923 BPH (benign prostatic hyperplasia). See Benign prostatic hyperplasia (BPH)

Bradycardia, 696, 698 Bradykinesia, 372, 373 Bradykinin, 231 Brain anatomy, 298–299 Brand names, 2, 5, 7 Breast cancer antineoplastic therapy, 217–218

Bimatoprost, 956 Bioavailability, 22 Biogenic amine, 316, 317 Biological weapons, 278, 282 Biologicals, 272, 273